Strides Pharma News Today

Moreover, Strides Pharma’s ambitious plans to launch approximately 60 new products in the US over the next three years further underscore its commitment to portfolio diversification and expansion. This forward-looking approach aligns with the company’s overarching objective of bolstering its market presence and addressing evolving healthcare needs. - Newsx

YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Tuesday, May 21, 2024.

Deep tech startup 8chili receives investment to lead way for healthcare workforce training

Generative artificial intelligence startup KonProz, healthtech startup Humors Tech and deeptech startup 8chili secured early-stage funding, the companies said on Monday. KonProz Generative AI startup KonProz has ......

It says Ebitda margins may reach 24.9%, boosted by product mix and cost control; long-term growth outlook positive, focused on complex products, domestic demand, and R&D investments

As per the affidavit filed with the Election Commission of India, Surya's main sources of income were investments in shares and mutual funds. He invested Rs 1.79 crore in shares and Rs 1.99 crore in mutual funds.

The companys Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food & Drug Administration (USFDA), the drug firm said in a regulatory filing.

Strides Pharma Share Price | It will respond to these observations comprehensively to FDA within the stipulated time, the pharmaceutical firm has said

The USFDA conducted a routine inspection of the formulations facility of Strides Alathur Private Limited, a wholly-owned subsidiary, in Chennai from April 1 to April 5.

The Bengaluru South MP’s assets jumped from Rs 13.46 lakh in 2019 to Rs 4.10 crore in 2024